News about Outsourcing

Pharmexcil seeks details on market access challenges faced by exporters in 8 regions including US, EU, Japan

Pharmexcil seeks details on market access challenges faced by exporters in 8 regions including US, EU, Japan

In a bid to enhance market access for Indian pharmaceuticals, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) has asked its member companies to furnish details of market access issues and non-tariff measures (NTMs) being faced them while exporting to countries like United States of America, European Union, Japan, Australia, Brazil

Outsourcing | 15/07/2021 | By Darshana 840

VectorBuilder and Univercells Technologies announce strategic partnership for optimized custom viral vector production

VectorBuilder and Univercells Technologies announce strategic partnership for optimized custom viral vector production

VectorBuilder a global leader in vector design, optimization and GMP manufacturing has formed a worldwide strategic partnership with Univercells Technologies, a provider of novel biomanufacturing technologies for flexible and scalable viral vector production

Outsourcing | 06/07/2021 | By Darshana 677

DRDO invites EoI to transfer technology of 2-DG drug for bulk production

DRDO invites EoI to transfer technology of 2-DG drug for bulk production

The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of Covid-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industries for production

Outsourcing | 10/06/2021 | By Darshana 705

FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma

FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma

Today, the U.S. Food and Drug Administration is providing an update on adverse events reported to the Agency related to breast implants, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and systemic signs and symptoms referred to by patients as breast implant illness (BII), which some patients report after receiving breast

Outsourcing | 21/08/2020 | By Darshana 1120

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members